Hemab Therapeutics Holdings Inc (COAG)

NASD · Healthcare · Biotechnology · USA

Hemab Therapeutics Holdings Inc is a small cap company (market value between $300 million and $2 billion) in the Biotechnology industry.

Intrinsic value, DCF valuation, financial health and value investing analysis for the Hemab Therapeutics Holdings Inc stock.

Our verdict on COAG

Not valued: We cannot value this company yet.

ETFs with the most weight in COAG

9 more funds hold it; the full list is part of the paid plan.

Browse

Peers in Biotechnology

All 600 Biotechnology stocks

Cheaper than COAG in Biotechnology

129 more in this industry show a wider margin of safety.

Is COAG undervalued or overvalued?

We do not publish a verdict on COAG yet. We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.

What is the intrinsic value of COAG?

We do not publish one (as of the 2026-11-17 close). We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.